MEDIROM Healthcare Technologies Inc. (MRM) Stock Score, Valuation & Financial Research
MEDIROM Healthcare Technologies Inc. is in the Consumer Cyclical sector and Personal Products & Services industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 18/100.
Quick answer for MRM
MEDIROM Healthcare Technologies Inc. currently has a Wall Street Score of 18/100. The stored market price is $0.83. Its financial score is 0/100. Its valuation score is 16/100. These figures are a research snapshot, not a buy or sell recommendation.
What MEDIROM Healthcare Technologies Inc. does
MEDIROM Healthcare Technologies Inc. (MRM) is a Japanese company that offers comprehensive healthcare solutions, operating through two primary divisions: Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment oversees a network of both company-owned and franchised wellness centers, which include brands like Re.Ra.Ku and Ruam Ruam. These salons deliver various therapeutic services, such as finger-pressure bodywork, stretch therapy, posture and joint alignment, and aspects of physical therapy. They also provide specialized treatments for fatigue relief, athletic support, weight management, and reflexology. By the close of 2021, this division managed 312 such relaxation salons. The Digital Preventative Healthcare segment is dedicated to proactive health management through technology. It participates in government-mandated Specific Health Guidance programs, primar
MRM financial snapshot
- Wall Street Score:
- 18/100
- Current price:
- $0.83
- Market capitalization:
- $4.2M
- Revenue:
- $73.7M
- Net income:
- $-2.8M
- Free cash flow:
- $-11.6M
- Cash:
- $123K
- Total debt:
- $14.3M
- EPS:
- 0.05
- P/E ratio:
- 18.3x
- Financial score:
- 0/100
- Valuation score:
- 16/100
- Revenue score:
- 40/100
What stands out
- Reported year-over-year revenue growth is +2984.2%.
- Free cash flow is $-11.6M, showing cash burn in the current stored period.
- The balance sheet shows $123K of cash versus $14.3M of total debt, so leverage deserves attention.
- The current research record carries a high debt stress warning, which should be reviewed alongside the score.
What the numbers mean
Its current valuation score is 16/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 0/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research MRM
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.